Literature DB >> 8818909

Incubation time for feline immunodeficiency virus cultures.

S Giannecchini1, D Matteucci, P Mazzetti, M Bendinelli.   

Abstract

In a recent report, Fiscus et al. (S. A. Fiscus, S. L. Welles, S. A. Spector, and J. L. Lathey, J. Clin. Microbiol. 33:246-247, 1995) have shown that qualitative human immunodeficiency virus cultures can be terminated at day 21 with minimal false-negative results. We have evaluated a large number of qualitative and quantitative feline immunodeficiency virus (FIV) isolations to determine how long FIV cultures should be incubated to obtain reasonably certain results. The rate at which FIV cultures became positive was influenced by whether the cats under study were naturally or experimentally infected, the duration of in vivo infection, and the number of infected peripheral blood mononuclear cells seeded. The results show that cultures for FIV isolation should be kept for 5 to 6 weeks.

Entities:  

Mesh:

Year:  1996        PMID: 8818909      PMCID: PMC229181          DOI: 10.1128/jcm.34.8.2036-2038.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  8 in total

1.  Length of incubation time for human immunodeficiency virus cultures.

Authors:  S A Fiscus; S L Welles; S A Spector; J L Lathey
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

2.  Analysis of a feline immunodeficiency virus provirus reveals patterns of gene sequence conservation distinct from human immunodeficiency virus type 1.

Authors:  D L Sodora; J Courcelle; J Brojatsch; A Berson; Y C Wang; S W Dow; E A Hoover; J I Mullins
Journal:  AIDS Res Hum Retroviruses       Date:  1995-04       Impact factor: 2.205

Review 3.  Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen.

Authors:  M Bendinelli; M Pistello; S Lombardi; A Poli; C Garzelli; D Matteucci; L Ceccherini-Nelli; G Malvaldi; F Tozzini
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

4.  The feline lymphoid cell line MBM and its use for feline immunodeficiency virus isolation and quantitation.

Authors:  D Matteucci; P Mazzetti; F Baldinotti; L Zaccaro; M Bendinelli
Journal:  Vet Immunol Immunopathol       Date:  1995-05       Impact factor: 2.046

5.  Primary stage of feline immunodeficiency virus infection: viral dissemination and cellular targets.

Authors:  A M Beebe; N Dua; T G Faith; P F Moore; N C Pedersen; S Dandekar
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

6.  Longitudinal assessment of feline immunodeficiency virus kinetics in plasma by use of a quantitative competitive reverse transcriptase PCR.

Authors:  L J Diehl; C K Mathiason-DuBard; L L O'Neil; E A Hoover
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

7.  CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication.

Authors:  C M Walker; D J Moody; D P Stites; J A Levy
Journal:  Science       Date:  1986-12-19       Impact factor: 47.728

8.  Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome.

Authors:  N C Pedersen; E W Ho; M L Brown; J K Yamamoto
Journal:  Science       Date:  1987-02-13       Impact factor: 47.728

  8 in total
  5 in total

1.  Studies of AIDS vaccination using an ex vivo feline immunodeficiency virus model: protection conferred by a fixed-cell vaccine against cell-free and cell-associated challenge differs in duration and is not easily boosted.

Authors:  D Matteucci; M Pistello; P Mazzetti; S Giannecchini; D Del Mauro; I Lonetti; L Zaccaro; C Pollera; S Specter; M Bendinelli
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Autologous and heterologous neutralization analyses of primary feline immunodeficiency virus isolates.

Authors:  D Del Mauro; D Matteucci; S Giannecchini; F Maggi; M Pistello; M Bendinelli
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

3.  Immunogenicity of an anti-clade B feline immunodeficiency fixed-cell virus vaccine in field cats.

Authors:  D Matteucci; A Poli; P Mazzetti; S Sozzi; F Bonci; P Isola; L Zaccaro; S Giannecchini; M Calandrella; M Pistello; S Specter; M Bendinelli
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: homologous erythrocytes as a delivery system for preferential immunization with putative protective antigens.

Authors:  L Chiarantini; D Matteucci; M Pistello; U Mancini; P Mazzetti; C Massi; S Giannecchini; I Lonetti; M Magnani; M Bendinelli
Journal:  Clin Diagn Lab Immunol       Date:  1998-03

5.  Kinetics of replication of a partially attenuated virus and of the challenge virus during a three-year intersubtype feline immunodeficiency virus superinfection experiment in cats.

Authors:  M Pistello; D Matteucci; G Cammarota; P Mazzetti; S Giannecchini; D Del Mauro; S Macchi; L Zaccaro; M Bendinelli
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.